Long-term Survival After Lung Transplantation Depends on Development and Severity of Bronchiolitis Obliterans Syndrome

Journal of Heart and Lung Transplantation

Volumn 26, Issue 7, 2007, Pages 681-686

  Burton, Christopher M ^a   Carlsen, Jørn ^a   Mortensen, Jann ^a   Andersen, Claus B ^a   Milman, Nils ^a   Iversen, Martin ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; DACLIZUMAB; FUSIDATE SODIUM; GANCICLOVIR; LYMPHOCYTE ANTIBODY; MEROPENEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; ROCEPHALIN; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VALGANCICLOVIR;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BRONCHIOLITIS OBLITERANS; CADAVER DONOR; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPROPHYLAXIS; LUNG FUNCTION; LUNG GRAFT REJECTION; LUNG INFECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PULMONARY HYPERTENSION; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; BRONCHIOLITIS OBLITERANS; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVORS;

EID: 34347258456     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.04.004     Document Type: Article

References (17)

1. Boehler A., and Estenne M. Obliterative bronchiolitis after lung transplantation. Curr Opin Pulm Med 6 (2000) 133-139
2. Cooper J.D., Billingham M., Egan T., et al., International Society for Heart and Lung Transplantation. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 12 (1993) 713-716
3. Trulock E.P., Edwards L.B., Taylor D.O., Boucek M.M., Keck B.M., and Hertz M.I. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report-2006. J Heart Lung Transplant 25 (2006) 880-892
4. Burton C.M., Milman N., Carlsen J., et al. Survival after single lung, double lung, and heart-lung transplantation. J Heart Lung Transplant 24 (2005) 1834-1843
5. Burton C.M., Andersen C.B., Jensen A.S., et al. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab. J Heart Lung Transplant 25 (2006) 638-647
6. Burton C.M., Kristensen P., Lutzhoft R., et al. Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient-donor serotype matching. Scand J Infect Dis 38 (2006) 281-289
7. Cooper J.D., Billingham M., Egan T., et al., International Society for Heart and Lung Transplantation. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 12 (1993) 713-716
8. Estenne M., Maurer J.R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21 (2002) 297-310
9. Haider Y., Yonan N., Mogulkoc N., Carroll K.B., and Egan J.J. Bronchiolitis obliterans syndrome in single lung transplant recipients-patients with emphysema versus patients with idiopathic pulmonary fibrosis. J Heart Lung Transplant 21 (2002) 327-333
10. Hadjiliadis D., Chaparro C., Gutierrez C., et al. Impact of lung transplant operation on bronchiolitis obliterans syndrome in patients with chronic obstructive pulmonary disease. Am J Transplant 6 (2006) 183-189
11. Reichenspurner H., Girgis R.E., Robbins R.C., et al. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 62 (1996) 1467-1472
12. Meyers B.F., Lynch J., Trulock E.P., Guthrie T.J., Cooper J.D., and Patterson G.A. Lung transplantation: a decade of experience. Ann Surg 230 (1999) 362-370
13. Moffatt S.D., Demers P., Robbins R.C., et al. Lung transplantation: a decade of experience. J Heart Lung Transplant 24 (2005) 145-151
14. Sundaresan S., Trulock E.P., Mohanakumar T., Cooper J.D., Patterson G.A., and Washington University Lung Transplant Group. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Ann Thorac Surg 60 (1995) 1341-1346
15. Heng D., Sharples L.D., McNeil K., Stewart S., Wreghitt T., and Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 17 (1998) 1255-1263
16. Aydemir U., Aydemir S., and Dirschedl P. Analysis of time-dependent covariates in failure time data. Stat Med 18 (1999) 2123-2134
17. Brugière O., Pessione F., Thabut G., et al. Bronchiolitis obliterans syndrome after single-lung transplantation: impact of time to onset on functional pattern and survival. Chest 121 (2002) 1883-1889